Inhibition and oxygen activation in copper amine oxidases

Area of Science:

• Biochemistry
• Enzymology
• Medicinal Chemistry

Background:

• Copper-containing amine oxidases (CuAOs) are enzymes that catalyze the oxidative deamination of primary amines.
• These enzymes utilize a copper cofactor and 2,4,5-trihydroxyphenylalanine quinone (TPQ) in their active site.
• The active site's structure and cofactor accessibility vary across different CuAO sources, influencing substrate specificity and inhibitor interactions.

Purpose of the Study:

• To summarize strategies for designing selective CuAO inhibitors based on active site channel characteristics.
• To provide a framework for developing molecules that minimize adverse effects of amine-containing drugs.
• To discuss the roles of copper and TPQ in O2 activation and substrate oxidation mechanisms.

Main Methods:

• Structural analysis of CuAO active sites and channels.
• Mechanistic studies involving kinetics, metal substitution, and spectroscopic methods (stopped-flow, temperature-jump relaxation).
• Oxygen kinetic isotope experiments to elucidate electron transfer pathways.

Main Results:

• Selective CuAO inhibitors can be designed by exploiting active site channel features for enhanced steric fit or trapping of reactive products.
• Evidence supports an inner-sphere electron transfer mechanism for O2 activation at the Cu(I) site in some CuAOs.
• Both inner-sphere and outer-sphere electron transfer mechanisms may operate in O2 activation by different CuAO forms.

Conclusions:

• Understanding CuAO structure-activity relationships is crucial for developing targeted inhibitors.
• Selective inhibition of specific amine oxidases can mitigate drug-induced side effects.
• Elucidation of O2 activation mechanisms provides insights into enzyme catalysis and potential drug interactions.